Atlas Trials

Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease

Clinical trial NCT02111122 · COMPLETED

Trial details

NCT number
NCT02111122
Sponsor
Christian Baumann
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sleep-wake Disturbances in Motor-phase Parkinson's Disease
Start date
2014-04-01
Primary completion
2016-04-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.